Robert D. Koler

1.6k total citations
31 papers, 1.2k citations indexed

About

Robert D. Koler is a scholar working on Physiology, Genetics and Cell Biology. According to data from OpenAlex, Robert D. Koler has authored 31 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Physiology, 14 papers in Genetics and 11 papers in Cell Biology. Recurrent topics in Robert D. Koler's work include Erythrocyte Function and Pathophysiology (15 papers), Hemoglobinopathies and Related Disorders (12 papers) and Hemoglobin structure and function (11 papers). Robert D. Koler is often cited by papers focused on Erythrocyte Function and Pathophysiology (15 papers), Hemoglobinopathies and Related Disorders (12 papers) and Hemoglobin structure and function (11 papers). Robert D. Koler collaborates with scholars based in United States, United Kingdom and Australia. Robert D. Koler's co-authors include Demetrios A. Rigas, Richard T. Jones, Edwin E. Osgood, Bernadine Brimhall, R. Bigley, Frederick Hecht, B. Kaiser McCaw, David Kabat, Leonard H. Evans and Corinne C. Sherton and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Robert D. Koler

31 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert D. Koler United States 19 504 367 335 329 325 31 1.2k
Edward R. Burka United States 18 354 0.7× 101 0.3× 253 0.8× 277 0.8× 527 1.6× 61 1.2k
Stephen H. Robinson United States 23 243 0.5× 141 0.4× 302 0.9× 302 0.9× 510 1.6× 51 1.2k
H. D. Waller Germany 18 188 0.4× 99 0.3× 278 0.8× 208 0.6× 255 0.8× 92 1.1k
J. D. Lutton United States 22 414 0.8× 162 0.4× 287 0.9× 528 1.6× 859 2.6× 69 1.8k
EA Rachmilewitz Israel 22 969 1.9× 139 0.4× 619 1.8× 895 2.7× 434 1.3× 57 1.7k
J. B. Wilson United States 24 1.8k 3.6× 850 2.3× 602 1.8× 1.1k 3.4× 464 1.4× 144 2.6k
H. H. Liem United States 17 165 0.3× 322 0.9× 129 0.4× 120 0.4× 540 1.7× 40 968
G Stamatoyannopoulos United States 29 1.5k 3.0× 136 0.4× 618 1.8× 1.1k 3.4× 999 3.1× 104 2.6k
Gibbons G. Cornwell United States 22 217 0.4× 275 0.7× 577 1.7× 343 1.0× 1.7k 5.3× 52 2.3k
Bregt Roerdinkholder‐Stoelwinder Netherlands 12 237 0.5× 160 0.4× 945 2.8× 363 1.1× 379 1.2× 15 1.4k

Countries citing papers authored by Robert D. Koler

Since Specialization
Citations

This map shows the geographic impact of Robert D. Koler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert D. Koler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert D. Koler more than expected).

Fields of papers citing papers by Robert D. Koler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert D. Koler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert D. Koler. The network helps show where Robert D. Koler may publish in the future.

Co-authorship network of co-authors of Robert D. Koler

This figure shows the co-authorship network connecting the top 25 collaborators of Robert D. Koler. A scholar is included among the top collaborators of Robert D. Koler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert D. Koler. Robert D. Koler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jones, Richard T., et al.. (1987). Hemoglobin Chico [β66(E10)Lys→Thr]: A New Variant with Decreased Oxygen Affinity. Hemoglobin. 11(5). 453–464. 16 indexed citations
2.
Jones, Richard T., Charlotte Head, M. Shih, et al.. (1986). Hemoglobin Linkoping [β36 (C2) Pro→Thr] in a Large Finnish Family from Astoria, Oregon, USA. Hemoglobin. 10(5). 455–467. 10 indexed citations
3.
Anderson, Robert L., Grover C. Bagby, Kathryn Richert-Boe, R. Ellen Magenis, & Robert D. Koler. (1981). Therapy-related preleukemic syndrome. Cancer. 47(7). 1867–1871. 54 indexed citations
4.
Koler, Robert D., et al.. (1978). Micro-Column Method for the Determination of Hemoglobin Minor Fractions AIa+Band AIc. Hemoglobin. 2(1). 53–58. 23 indexed citations
5.
Turner, James, et al.. (1976). Characterization of hemoglobin Burke [β107 (G9) Gly→Arg]. Biochemical Genetics. 14(7-8). 577–585. 9 indexed citations
6.
Jones, Richard T., Robert D. Koler, Marie L. Duerst, & Dharam S. Dhindsa. (1976). Hemoglobain Willamette. [α2β251PRO→APG (D2)] A New Abnormal Huhah Hemoglobain. Hemoglobin. 1(1). 45–57. 8 indexed citations
7.
Kabat, David & Robert D. Koler. (1975). The Thalassemias: Models for Analysis of Quantitative Gene Control. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 5. 157–222. 4 indexed citations
8.
Kennaway, Nancy G., et al.. (1975). Citrullinemia: Enzymatic Evidence for Genetic Heterogeneity. Pediatric Research. 9(6). 554–558. 31 indexed citations
9.
Wajcman, Henri, Gérard Gâcon, Dominique Labie, Robert D. Koler, & Richard T. Jones. (1975). Isolation and functional characterization of hemoglobin Casper. β106(G8)Leu → Pro. Biochemistry. 14(22). 5017–5020. 14 indexed citations
10.
Koler, Robert D., Richard T. Jones, R. Bigley, et al.. (1973). Hemoglobin casper: β 106 (G8) Leu→Pro. The American Journal of Medicine. 55(4). 549–558. 37 indexed citations
11.
Fellman, J.H., et al.. (1969). Soluble and mitochondrial forms of tyrosine aminotransferase. Relation to human tyrosinemia. Biochemistry. 8(2). 615–622. 76 indexed citations
12.
Koler, Robert D., et al.. (1969). Ontogeny of Soluble and Mitochondrial Tyrosine Aminotransferases. Science. 163(3873). 1348–1350. 11 indexed citations
13.
Koler, Robert D., et al.. (1968). The mechanism of precursor modulation of human pyruvate kinase I by fructose diphosphate. Advances in Enzyme Regulation. 6. 127–142. 36 indexed citations
14.
Jones, Richard T., Edwin E. Osgood, Bernadine Brimhall, & Robert D. Koler. (1967). Hemoglobin Yakima: I. Clinical and Biochemical Studies*. Journal of Clinical Investigation. 46(11). 1840–1847. 99 indexed citations
15.
Koler, Robert D., et al.. (1966). Red Cell Survival in Patients with Mitral Valvular Disease and Mitral Valve Prostheses. Circulation. 33(4s1). I140–51. 18 indexed citations
16.
Koler, Robert D., et al.. (1965). Kinetic Differences between Human Red Cell and Leucocyte Pyruvate Kinase. Nature. 208(5006). 194–195. 27 indexed citations
17.
Siegel, Benjamin V., et al.. (1964). Mouse Erythroleukæmia of Viral Ætiology. Nature. 201(4923). 1042–1043. 15 indexed citations
18.
Edwards, Miles J., et al.. (1961). THE EFFECT OF IN VIVO AGING OF NORMAL HUMAN ERYTHROCYTES AND ERYTHROCYTE MACROMOLECULES UPON OXYHEMOGLOBIN DISSOCIATION*. Journal of Clinical Investigation. 40(4). 636–642. 20 indexed citations
19.
Rigas, Demetrios A., Robert D. Koler, & Edwin E. Osgood. (1955). New Hemoglobin Possessing a Higher Electrophoretic Mobility than Normal Adult Hemoglobin. Science. 121(3141). 372–372. 95 indexed citations
20.
Mann, Joseph D. & Robert D. Koler. (1951). The Excretion in the Bile of Urobilinogen Administered Orally and Parenterally. Gastroenterology. 17(3). 400–405. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026